{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:23:32Z","timestamp":1791933812771,"version":"4.3.4"},"reference-count":94,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"am","delay-in-days":283,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.mycmed.2023.101392","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T12:17:04Z","timestamp":1683202624000},"page":"101392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Allergic bronchopulmonary aspergillosis: A multidisciplinary review"],"prefix":"10.1016","volume":"33","author":[{"given":"Amytis","family":"Roboubi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Audousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9milie","family":"Fr\u00e9alle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Vitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Mortuaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Lefevre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Cadranel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6229-2075","authenticated-orcid":false,"given":"C\u00e9cile","family":"Chenivesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mycmed.2023.101392_bib0001","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/13693786.2012.738312","article-title":"Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults","volume":"51","author":"Denning","year":"2013","journal-title":"Med Mycol"},{"issue":"12","key":"10.1016\/j.mycmed.2023.101392_bib0002","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/cea.12595","article-title":"Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis","volume":"45","author":"Maturu","year":"2015","journal-title":"Clin Exp Allergy"},{"issue":"7","key":"10.1016\/j.mycmed.2023.101392_bib0003","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3109\/13693781003743148","article-title":"Aspergillus hypersensitivity in patients with chronic obstructive pulmonary disease: COPD as a risk factor for ABPA?","volume":"48","author":"Agarwal","year":"2010","journal-title":"Med Mycol"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101392_bib0004","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12931-014-0130-1","article-title":"The prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung function","volume":"15","author":"Jin","year":"2014","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.mycmed.2023.101392_bib0005","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1034\/j.1399-3003.2000.016003464.x","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis","volume":"16","author":"Mastella","year":"2000","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101392_bib0006","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.alit.2017.04.011","article-title":"Allergic bronchopulmonary aspergillosis in Japan: a nationwide survey","volume":"67","author":"Oguma","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.mycmed.2023.101392_bib0007","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.2147\/JAA.S389985","article-title":"The difference in all-cause mortality between allergic bronchopulmonary aspergillosis with and without chronic obstructive pulmonary disease","volume":"15","author":"Zhang","year":"2022","journal-title":"J Asthma Allergy"},{"issue":"2","key":"10.1016\/j.mycmed.2023.101392_bib0008","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1183\/13993003.01475-2015","article-title":"A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"47","author":"Agarwal","year":"2016","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.mycmed.2023.101392_bib0009","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/EC.00274-07","article-title":"Aspergillus fumigatus: principles of pathogenesis and host defense","volume":"6","author":"Hohl","year":"2007","journal-title":"Eukaryot Cell"},{"issue":"Supplement_2","key":"10.1016\/j.mycmed.2023.101392_bib0010","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1093\/mmy\/myy076","article-title":"Pathophysiological aspects of Aspergillus colonization in disease","volume":"57","author":"Gago","year":"2019","journal-title":"Med Mycol"},{"issue":"8","key":"10.1016\/j.mycmed.2023.101392_bib0011","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/02770903.2017.1373808","article-title":"F508del CFTR gene mutation in patients with allergic bronchopulmonary aspergillosis","volume":"55","author":"Gamaletsou","year":"2018","journal-title":"J Asthma"},{"key":"10.1016\/j.mycmed.2023.101392_bib0012","unstructured":"GINA, https:\/\/ginasthma.org (report 2022 )"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101392_bib0013","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.jcf.2019.02.002","article-title":"CT evaluation of hyperattenuating mucus to diagnose allergic bronchopulmonary aspergillosis in the special condition of cystic fibrosis","volume":"18","author":"Refait","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101392_bib0014","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4329\/wjr.v4.i4.141","article-title":"Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis","volume":"4","author":"Agarwal","year":"2012","journal-title":"World J Radiol"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101392_bib0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0954-6111(97)90041-X","article-title":"Allergic bronchopulmonary aspergillosis: the spectrum of computed tomography appearances","volume":"91","author":"Panchal","year":"1997","journal-title":"Respir Med"},{"issue":"12","key":"10.1016\/j.mycmed.2023.101392_bib0016","doi-asserted-by":"crossref","first-page":"e15346","DOI":"10.1371\/journal.pone.0015346","article-title":"An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus","volume":"5","author":"Agarwal","year":"2010","journal-title":"PLOS One"},{"issue":"7","key":"10.1016\/j.mycmed.2023.101392_bib0017","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.rmed.2012.03.001","article-title":"Serologic allergic bronchopulmonary aspergillosis (ABPA-S): long-term outcomes","volume":"106","author":"Agarwal","year":"2012","journal-title":"Respir Med"},{"issue":"8","key":"10.1016\/j.mycmed.2023.101392_bib0018","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/mmy\/myz004","article-title":"Multi-centric evaluation of the online MSI platform for the identification of cryptic and rare species of Aspergillus by MALDI-TOF","volume":"57","author":"Imbert","year":"2019","journal-title":"Med Mycol"},{"issue":"12","key":"10.1016\/j.mycmed.2023.101392_bib0019","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01374-20","article-title":"Multicentric analysis of the species distribution and antifungal susceptibility of cryptic isolates from Aspergillus section Fumigati","volume":"64","author":"Imbert","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101392_bib0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/1040841X.2012.754401","article-title":"Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview","volume":"40","author":"Chowdhary","year":"2014","journal-title":"Crit Rev Microbiol"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101392_bib0021","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/0003-4819-86-4-405","article-title":"Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis","volume":"86","author":"Rosenberg","year":"1977","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101392_bib0022","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jaip.2020.08.043","article-title":"Which are the optimal criteria for the diagnosis of allergic bronchopulmonary Aspergillosis? A latent class analysis","volume":"9","author":"Saxena","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101392_bib0023","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jaci.2020.08.029","article-title":"Japan ABPM Research Program. New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis\/mycosis and its validation","volume":"147","author":"Asano","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.mycmed.2023.101392_bib0024","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"ABPA complicating asthma ISHAM working group. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal","year":"2013","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.mycmed.2023.101392_bib0025","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jaip.2014.08.007","article-title":"Allergic bronchopulmonary aspergillosis","volume":"2","author":"Greenberger","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.mycmed.2023.101392_bib0026","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM200003163421102","article-title":"A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis","volume":"342","author":"Stevens","year":"2000","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.mycmed.2023.101392_bib0027","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.chest.2018.01.005","article-title":"A randomized trial of itraconazole vs prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"153","author":"Agarwal","year":"2018","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.mycmed.2023.101392_bib0028","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01159-2018","article-title":"A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"52","author":"Agarwal","year":"2018","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101392_bib0029","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01787-2021","article-title":"A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"59","author":"Agarwal","year":"2021","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101392_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/myc.12423","article-title":"A. Utility of IgE (total and Aspergillus fumigatus specific) in monitoring for response and exacerbations in allergic bronchopulmonary aspergillosis","volume":"59","author":"Agarwal","year":"2016","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.mycmed.2023.101392_bib0031","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5662\/wjm.v8.i3.17","article-title":"Precision medicine allergy immunoassay methods for assessing immunoglobulin E sensitization to aeroallergen molecules","volume":"8","author":"Popescu","year":"2018","journal-title":"World J Methodol"},{"issue":"11","key":"10.1016\/j.mycmed.2023.101392_bib0032","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/myc.12214","article-title":"Cut-off values of serum IgE (total and A. fumigatus -specific) and eosinophil count in differentiating allergic bronchopulmonary aspergillosis from asthma","volume":"57","author":"Agarwal","year":"2014","journal-title":"Mycoses"},{"issue":"9","key":"10.1016\/j.mycmed.2023.101392_bib0033","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/cea.13216","article-title":"Utility of recombinant Aspergillus fumigatus antigens in the diagnosis of allergic bronchopulmonary aspergillosis: a systematic review and diagnostic test accuracy meta-analysis","volume":"48","author":"Muthu","year":"2018","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101392_bib0034","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/myc.12541","article-title":"Role of Aspergillus fumigatus-specific IgG in diagnosis and monitoring treatment response in allergic bronchopulmonary aspergillosis","volume":"60","author":"Agarwal","year":"2017","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101392_bib0035","doi-asserted-by":"crossref","first-page":"E197","DOI":"10.1111\/1469-0691.12133","article-title":"Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis","volume":"19","author":"Baxter","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101392_bib0036","doi-asserted-by":"crossref","first-page":"e61105","DOI":"10.1371\/journal.pone.0061105","article-title":"Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis","volume":"8","author":"Agarwal","year":"2013","journal-title":"PLOS One"},{"key":"10.1016\/j.mycmed.2023.101392_bib0037","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.alit.2018.04.009","article-title":"Concordance between Aspergillus-specific precipitating antibody and IgG in allergic bronchopulmonary aspergillosis","volume":"67S","author":"Harada","year":"2018","journal-title":"Allergol Int"},{"issue":"2","key":"10.1016\/j.mycmed.2023.101392_bib0038","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00181147","article-title":"Abnormalities of the airways and lung parenchyma in asthmatics: CT observations in 50 patients and inter- and intraobserver variability","volume":"6","author":"Grenier","year":"1996","journal-title":"Eur Radiol"},{"key":"10.1016\/j.mycmed.2023.101392_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.861866","article-title":"Evaluation of simpler criteria for diagnosing allergic bronchopulmonary Aspergillosis complicating asthma","volume":"12","author":"Agarwal","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"10.1016\/j.mycmed.2023.101392_bib0040","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/02770903.2013.796973","article-title":"Allergic bronchopulmonary aspergillosis: a clinico-serological correlation with radiologic profile","volume":"50","author":"Kumar","year":"2013","journal-title":"J Asthma"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101392_bib0041","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1378\/chest.07-0808","article-title":"Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients","volume":"132","author":"Agarwal","year":"2007","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.mycmed.2023.101392_bib0042","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/alr.21352","article-title":"Medical management of allergic fungal rhinosinusitis following endoscopic sinus surgery: an evidence-based review and recommendations","volume":"4","author":"Gan","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101392_bib0043","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2500\/ajr.2007.21.3051","article-title":"Allergic fungal sinusitis associated with allergic bronchopulmonary aspergillosis: an uncommon sinobronchial allergic mycosis","volume":"21","author":"Braun","year":"2007","journal-title":"Am J Rhinol"},{"issue":"Suppl 1","key":"10.1016\/j.mycmed.2023.101392_bib0044","article-title":"Allergic fungal sinusitis: pathophysiology, diagnosis and management","volume":"47","author":"Schubert","year":"2009","journal-title":"Med Mycol"},{"issue":"3","key":"10.1016\/j.mycmed.2023.101392_bib0045","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4103\/0970-2113.135762","article-title":"A questionnaire-based study on the role of environmental factors in allergic bronchopulmonary Aspergillosis","volume":"31","author":"Agarwal","year":"2014","journal-title":"Lung India"},{"issue":"2","key":"10.1016\/j.mycmed.2023.101392_bib0046","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2222.1980.tb02100.x","article-title":"Environmental factors in allergic bronchopulmonary aspergillosis","volume":"10","author":"Vernon","year":"1980","journal-title":"Clin Allergy"},{"issue":"3","key":"10.1016\/j.mycmed.2023.101392_bib0047","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2222.1983.tb02598.x","article-title":"Mould counts and exacerbations of allergic bronchopulmonary Aspergillosis","volume":"13","author":"Radin","year":"1983","journal-title":"Clin Allergy"},{"issue":"5","key":"10.1016\/j.mycmed.2023.101392_bib0048","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/archinte.1986.00360170130020","article-title":"Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies","volume":"146","author":"Patterson","year":"1986","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.mycmed.2023.101392_bib0049","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.44.11.925","article-title":"Corticosteroid treatment and prognosis in pulmonary eosinophilia","volume":"44","author":"Capewell","year":"1989","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101392_bib0050","first-page":"87","article-title":"The management of allergic bronchopulmonary aspergillosis","volume":"120","author":"Wang","year":"1979","journal-title":"Am Rev Respir Dis"},{"issue":"10","key":"10.1016\/j.mycmed.2023.101392_bib0051","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/cea.12333","article-title":"Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review","volume":"44","author":"Moreira","year":"2014","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101392_bib0052","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01147-2019","article-title":"Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma","volume":"55","author":"Maijers","year":"2020","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.mycmed.2023.101392_bib0053","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2169\/internalmedicine.50.4665","article-title":"Role of inhaled corticosteroids in the management of serological allergic bronchopulmonary aspergillosis (ABPA)","volume":"50","author":"Agarwal","year":"2011","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101392_bib0054","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mycmed.2023.101392_bib0055","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/02770903.2015.1127935","article-title":"A pilot randomized trial of nebulized amphotericin in patients with allergic bronchopulmonary aspergillosis","volume":"53","author":"Ram","year":"2016","journal-title":"J Asthma"},{"issue":"6","key":"10.1016\/j.mycmed.2023.101392_bib0056","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02218-2021","article-title":"Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial","volume":"59","author":"Godet","year":"2022","journal-title":"Eur Respir J"},{"issue":"165","key":"10.1016\/j.mycmed.2023.101392_bib0057","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0011-2022","article-title":"Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review","volume":"31","author":"Manti","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"9","key":"10.1016\/j.mycmed.2023.101392_bib0058","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1398-9995.2011.02599.x","article-title":"Allergic bronchopulmonary aspergillosis and omalizumab","volume":"66","author":"Tillie-Leblond","year":"2011","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.mycmed.2023.101392_bib0059","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.jaip.2020.03.023","article-title":"Mepolizumab for allergic bronchopulmonary aspergillosis: report of 20 cases from the Belgian Severe Asthma Registry and review of the literature","volume":"8","author":"Schleich","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.mycmed.2023.101392_bib0060","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejim.2021.12.026","article-title":"One-year mepolizumab for allergic bronchopulmonary aspergillosis: focus on steroid sparing effect and markers of response","volume":"99","author":"Caminati","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.mycmed.2023.101392_bib0061","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaip.2014.12.008","article-title":"Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis","volume":"3","author":"Voskamp","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1\u20132","key":"10.1016\/j.mycmed.2023.101392_bib0062","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jim.2005.06.008","article-title":"Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving omalizumab (Xolair) therapy","volume":"303","author":"Hamilton","year":"2005","journal-title":"J Immunol Methods"},{"issue":"11","key":"10.1016\/j.mycmed.2023.101392_bib0063","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.rmed.2012.07.010","article-title":"Monitoring free serum IgE in severe asthma patients treated with omalizumab","volume":"106","author":"Korn","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.mycmed.2023.101392_bib0064","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3389\/fimmu.2018.02346","article-title":"Allergic bronchopulmonary Aspergillosis-A luminal hypereosinophilic disease with extracellular trap cell death","volume":"9","author":"Ueki","year":"2018","journal-title":"Front Immunol"},{"issue":"5\u20136","key":"10.1016\/j.mycmed.2023.101392_bib0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jiph.2011.08.006","article-title":"Clinical relevance of peripheral blood eosinophil count in allergic bronchopulmonary aspergillosis","volume":"4","author":"Agarwal","year":"2011","journal-title":"J Infect Public Health"},{"issue":"Suppl S29","key":"10.1016\/j.mycmed.2023.101392_bib0066","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101392_bib0067","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00405-019-05650-y","article-title":"Omalizumab versus intranasal steroids in the post-operative management of patients with allergic fungal rhinosinusitis","volume":"277","author":"Mostafa","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"3","key":"10.1016\/j.mycmed.2023.101392_bib0068","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/jof6030122","article-title":"Review of the novel investigational antifungal olorofim","volume":"6","author":"Wiederhold","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101392_bib0069","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/jof6040239","article-title":"Fosmanogepix: a review of the first-in-class broad spectrum agent for the treatment of invasive fungal infections","volume":"6","author":"Shaw","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"8","key":"10.1016\/j.mycmed.2023.101392_bib0070","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/all.13109","article-title":"A novel bispecific DARPin targeting Fc\u03b3RIIB and Fc\u03b5RI-bound IgE inhibits allergic responses","volume":"72","author":"Zellweger","year":"2017","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.mycmed.2023.101392_bib0071","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.jaci.2014.02.005","article-title":"Accelerated dissociation of IgE-Fc\u03b5RI complexes by disruptive inhibitors actively desensitizes allergic effector cells","volume":"133","author":"Eggel","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101392_bib0072","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","article-title":"Development of the asthma control test: a survey for assessing asthma control","volume":"113","author":"Nathan","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101392_bib0073","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101392_bib0074","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0002-9343(79)90246-8","article-title":"Acute and chronic pulmonary function changes in allergic bronchopulmonary Aspergillosis","volume":"67","author":"Nichols","year":"1979","journal-title":"Am J Med"},{"issue":"10059","key":"10.1016\/j.mycmed.2023.101392_bib0075","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"issue":"Supplement_2","key":"10.1016\/j.mycmed.2023.101392_bib0076","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1093\/mmy\/myy074","article-title":"Aspergillus colonization and antifungal immunity in cystic fibrosis patients","volume":"57","author":"Warris","year":"2019","journal-title":"Med Mycol"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101392_bib0077","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11046-017-0184-y","article-title":"Fungal pathogens in CF airways: leave or treat?","volume":"183","author":"Singh","year":"2018","journal-title":"Mycopathologia"},{"issue":"3","key":"10.1016\/j.mycmed.2023.101392_bib0078","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1164\/rccm.201106-1027OC","article-title":"Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation","volume":"185","author":"Chaudhary","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.mycmed.2023.101392_bib0079","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s11046-021-00541-5","article-title":"CF fungal disease in the age of CFTR modulators","volume":"186","author":"Bercusson","year":"2021","journal-title":"Mycopathologia"},{"issue":"6","key":"10.1016\/j.mycmed.2023.101392_bib0080","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1165\/rcmb.2010-0224OC","article-title":"Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses","volume":"44","author":"Mueller","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.mycmed.2023.101392_bib0081","first-page":"S225","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis\u2013state of the art: cystic fibrosis foundation consensus conference","volume":"37","author":"Stevens","year":"2003"},{"issue":"5","key":"10.1016\/j.mycmed.2023.101392_bib0082","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jcf.2018.01.008","article-title":"Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis","volume":"17","author":"Hong","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"11","key":"10.1016\/j.mycmed.2023.101392_bib0083","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1007\/s00330-016-4218-5","article-title":"Lung morphology assessment of cystic fibrosis using MRI with ultra-short echo time at submillimeter spatial resolution","volume":"26","author":"Dournes","year":"2016","journal-title":"Eur Radiol"},{"issue":"9","key":"10.1016\/j.mycmed.2023.101392_bib0084","article-title":"Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis","volume":"9","author":"Francis","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.mycmed.2023.101392_bib0085","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1378\/chest.115.2.364","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole","volume":"115","author":"Nepomuceno","year":"1999","journal-title":"Chest"},{"issue":"10290","key":"10.1016\/j.mycmed.2023.101392_bib0086","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101392_bib0087","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jcf.2009.04.008","article-title":"Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis","volume":"8","author":"Cohen-Cymberknoh","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.mycmed.2023.101392_bib0088","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/jac\/dkz075","article-title":"Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis","volume":"74","author":"Periselneris","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.mycmed.2023.101392_bib0089","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/AAC.05077-11","article-title":"High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole","volume":"56","author":"Burgel","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101392_bib0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcf.2019.07.011","article-title":"Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis","volume":"19","author":"Koutsokera","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"17","key":"10.1016\/j.mycmed.2023.101392_bib0091","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX16-445-001 study group. VX-445-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.mycmed.2023.101392_bib0092","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"VX17-445-102 study group. elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.mycmed.2023.101392_bib0093","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cells11111769","article-title":"CFTR modulators in people with cystic fibrosis: real-world evidence in France","volume":"11","author":"Regard","year":"2022","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.mycmed.2023.101392_bib0094","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1513\/AnnalsATS.201902-122OC","article-title":"Ivacaftor is associated with reduced lung infection by key cystic fibrosis pathogens. A cohort study using national registry data","volume":"16","author":"Frost","year":"2019","journal-title":"Ann Am Thorac Soc"}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523323000367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523323000367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:22:37Z","timestamp":1761110557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523323000367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1156523323000367"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2023.101392","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allergic bronchopulmonary aspergillosis: A multidisciplinary review","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2023.101392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 SFMM. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101392"}}